ICF International Amends Credit Agreement, Boosting Term Loan by $150M and Extending Maturity to 2031
Summary
ICF International, Inc. amended its credit agreement, increasing its term loan facility by $150 million to $450 million and extending the maturity date to April 2031, enhancing financial flexibility and supporting strategic growth.
Key Events
-
Term Loan Facility Increase
The term loan facility was increased from $300.0 million to $450.0 million, providing an additional $150 million in capital.
-
Maturity Date Extended
The maturity date for the credit facility was extended from May 6, 2022 (original agreement date) to April 10, 2031, enhancing long-term financial stability.
-
Revolving Credit and Delayed Draw Term Loan Maintained
The $600.0 million revolving credit facility and the $400.0 million delayed draw term loan facility were maintained at their existing levels.
-
Incremental Credit Facility Expansion
The incremental credit facility was increased, offering greater flexibility for future debt issuance up to the greater of $300.0 million and 100% of Consolidated EBITDA, plus voluntary prepayments.
Analysis
ICF International, Inc. has significantly enhanced its financial flexibility and long-term stability by amending and restating its credit agreement. The increase in the term loan facility by $150 million provides substantial additional capital, which is particularly notable given the company's reported decline in 2025 revenue and net income. This capital can be used for refinancing existing debt, funding Permitted Acquisitions, and general corporate purposes, supporting the company's strategic growth initiatives. The extension of the maturity date to April 2031 also provides a longer runway for operations and debt management, reducing near-term refinancing risks. The adjusted net leverage ratio covenant offers more flexibility for future material acquisitions, indicating a proactive approach to M&A strategy.
At the time of this filing, ICFI was trading at $72.91 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $64.34 to $101.71. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.